KaloBios Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

02.05.18	Waste Connections Reports First Quarter 2018 Results (PR Newswire)
30.08.16	KBIO In Detox Mode, CTIC Abuzz, MYL Does Damage Control, D-Day For RIGL (RTTNews)
29.08.16	KaloBios Pharma Announces Martin Shkreli's Sale Of His Stake In Company (RTTNews)
04.07.16	BIND Gallups On Stalking Horse Offer, KBIO Is Back, ALNY Abuzz (RTTNews)
13.01.16	ABBV All Set, PSTI Moving Ahead, Watch Out For ADMS (RTTNews)
12.01.16	Nasdaq To Suspend KaloBios Pharma On Jan 13 (RTTNews)
30.12.15	KaloBios Files For Bankruptcy (RTTNews)
30.12.15	KaloBios Announces Submission Of Request For Appeal Of Nasdaq Delisting (RTTNews)
28.12.15	Tom Fernandez And Marek Biestek Resign From KaloBios Board (RTTNews)
24.12.15	KaloBios Interim CFO Thorn Resigns; Gets Delisting Notice From Nasdaq (RTTNews)
17.12.15	Pharma Bad Boy Martin Shkreli Arrested (RTTNews)
20.11.15	KaloBios Appoints Martin Shkreli As CEO, Obtains New Financing Commitment (RTTNews)
06.11.15	EYEG Catches Investors' Eyes, FDA Approves GILD's HIV Pill, KBIO Lays Off Staff (RTTNews)
09.01.15	KaloBios President And CEO David Pritchard Retires - Quick Facts (RTTNews)
07.01.15	ALKS Moves Forward, KBIO Craters, GILD Opens Wallet, TRVN For The Long Haul (RTTNews)
07.01.15	KaloBios Plunges As KB001-A Fails To Meet Primary End Points In CF Patients (RTTNews)
29.07.14	KaloBios Regains Global Rights To KB001-A, Ends Deal With Sanofi Pasteur (RTTNews)
29.07.14	KaloBios Regains Global Rights To KB001-A From Sanofi Pasteur (RTTNews)
29.07.14	After-market Movers For July 28 (HLF, HLS, CGNX, KBIO, TRGT) (RTTNews)
12.02.14	CADX Snapped Up, HNSN Gets FDA Nod, NNVC Rejects Report's Claims, NVLT Renamed (RTTNews)
30.01.14	KaloBios: KB003 Fails To Meet Primary Goal In Phase 2 Asthma Study (RTTNews)
30.01.14	DEPO Prevails In Markman Hearing, IDIX, KBIO Get Smacked, ONVO Ahead Of Target (RTTNews)
30.01.14	KaloBios Pharma's Phase 2 Study Of KB003 Fails To Meet Primary Endpoint (RTTNews)
29.01.14	After-market Movers For Jan 29 (FB, QCOM, FLEX, NSR, KBIO) (RTTNews)
10.12.13	KaloBios Reports Preliminary Results From Ongoing Phase 1 Study Of KB004 (RTTNews)
01.10.13	KaloBios Pharmaceuticals, Inc. Announces Closing of Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares (PR Newswire)
30.09.13	KaloBios to Present at Leerink Swann Rare Disease Roundtable (PR Newswire)
26.09.13	Pre-market Movers For Sept 26 (FB, HTZ, LLY, FLOW, USAK, KBIO, WPRT) (RTTNews)
26.09.13	KaloBios Pharmaceuticals, Inc. Prices Public Offering of Common Stock (PR Newswire)
23.09.13	KaloBios to Present at BioCentury's NewsMakers in the Biotech Industry Conference (PR Newswire)
19.09.13	Herb C. Cross to Join KaloBios as Chief Financial Officer (PR Newswire)
18.09.13	KaloBios' KB001 Anti-Pseudomonas Antibody Study Published in Pediatric Pulmonology (PR Newswire)
05.09.13	KaloBios to Present at Stifel Healthcare Conference 2013 (PR Newswire)
19.08.13	KaloBios Pharmaceuticals Q2 Loss Widens (RTTNews)
19.08.13	KaloBios Reports Second Quarter 2013 Financial Results (PR Newswire)
07.08.13	KaloBios Appoints V. Bryan Lawlis, Jr., Ph.D. to Board of Directors (PR Newswire)
05.08.13	KaloBios Announces Retirement Of Chief Financial Officer (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

ABB	53.56	3.72 %	K V
Sonova Hldg	318.50	3.11 %	K V
Part Grp Hldg	1’381.00	2.30 %	K V
Alcon	80.90	1.81 %	K V
Lonza Grp	580.40	1.79 %	K V
Nestle	74.18	-0.75 %	K V
Geberit	500.80	-0.91 %	K V
Kuehne+Nagel Int	204.60	-1.06 %	K V
Swisscom	506.50	-1.65 %	K V
Logitech Intl	79.90	-1.75 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu KaloBios Pharmaceuticals Inc

Aktien Top/Flop

Meistgelesene Nachrichten